Clinical Trial Update: INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 INNATE trial evaluating immunotherapy during neoadjuvant therapy for locally advanced rectal cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Locally Advanced Rectal Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING